Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
GBT
Global Blood Therapeutics
10
Follow
10
GBT
Global Blood Therapeutics
10
Follow
10
Full Editor
Login/Register
Likes Subject
$GBT: August 19 $70 calls just shot up..... makinezmoney 08/05/22 12:04 PM
Zacks Equity Research Paullee 12/20/21 4:30 PM
Sounds good Golden Cross 09/07/21 9:22 AM
Priority reviews Paullee 09/07/21 8:18 AM
Goldman Buy Today target 103 from 91 Golden Cross 07/01/20 7:24 AM
5 Best Mid-Cap Biotech Acquisition Targets Timetravelerdos 12/30/19 4:33 PM
Just keeps going up and up! making new Timetravelerdos 12/26/19 12:48 PM
What a day so far up over $3 Timetravelerdos 12/23/19 12:06 PM
Opinion: Biotech stocks are producing outsized gains — Timetravelerdos 12/11/19 12:51 PM
Global Blood Therapeutics: Oxbryta Is Aimed For Success Timetravelerdos 12/04/19 11:56 AM
https://www.nytimes.com/2019/01/27/health/sickle-cell-gene-therapy.html biotech_researcher 01/27/19 6:51 AM
The unique statistics formula that has 83% accuracy TradersFish 05/05/18 11:15 PM
What turd! Company is going under Goldmind 04/05/18 1:25 PM
GBT buy 57.15 stocktrademan 02/11/18 12:55 PM
$GBT Reports Recent Business Progress and Provides Third Maxgambit 11/03/17 10:26 AM
https://seekingalpha.com/article/4115611-global-blood-therapeutics-drops-idiopat Inoviorulez 10/23/17 6:54 PM
Since selling half my shares @ $37.50, I Transparency 05/09/17 12:09 PM
Between upcoming data points (adolescent SCD, IPF, & eneels01 05/06/17 9:53 AM
She is busting out now! Transparency 03/09/17 12:31 PM
GBT bearish 17.50 stocktrademan 12/05/16 11:58 AM
What a beast ClearlyStocks 08/12/16 6:18 PM
Well that was good for a pop to Whalatane 06/16/16 11:52 AM
A dead Board ...may be a good sign ..:>) Whalatane 06/02/16 7:43 PM
Movers and Shakers: The Week so Far - venturecapp 12/08/15 1:20 PM
EPS= -1.51 TREND1 08/20/15 2:39 PM
There is not enough data on the chart TREND1 08/19/15 11:51 PM
Oh I see you posted a chart, pics protagonist12 08/19/15 11:51 PM
I would like to know what your take protagonist12 08/19/15 11:49 PM
What do you want to know about ? TREND1 08/19/15 11:48 PM
What about it? protagonist12 08/19/15 11:44 PM
GBT daily chart TREND1 08/19/15 11:41 PM
GBT D? protagonist12 08/19/15 11:38 PM
GBT D 4 MONTHS TREND1 08/19/15 10:07 PM
Yeah not thrilled about it pricing $2 above protagonist12 08/11/15 10:08 PM
Worth 20? Not really sure, if thats it librarianlover 08/11/15 9:16 PM
Global Blood Therapeutics, an early-stage biotech developing a protagonist12 08/11/15 7:07 PM
Likes Subject

makinezmoney
08/05/22 12:04 PM
Paullee
12/20/21 4:30 PM
Golden Cross
09/07/21 9:22 AM
Paullee
09/07/21 8:18 AM
Golden Cross
07/01/20 7:24 AM
Timetravelerdos
12/30/19 4:33 PM
Timetravelerdos
12/26/19 12:48 PM
Timetravelerdos
12/23/19 12:06 PM
Timetravelerdos
12/11/19 12:51 PM
Timetravelerdos
12/04/19 11:56 AM
biotech_researcher
01/27/19 6:51 AM
TradersFish
05/05/18 11:15 PM
Goldmind
04/05/18 1:25 PM
stocktrademan
02/11/18 12:55 PM
Maxgambit
11/03/17 10:26 AM
Inoviorulez
10/23/17 6:54 PM
Transparency
05/09/17 12:09 PM
eneels01
05/06/17 9:53 AM
Transparency
03/09/17 12:31 PM
stocktrademan
12/05/16 11:58 AM
ClearlyStocks
08/12/16 6:18 PM
Whalatane
06/16/16 11:52 AM
Whalatane
06/02/16 7:43 PM
venturecapp
12/08/15 1:20 PM
TREND1
08/20/15 2:39 PM
TREND1
08/19/15 11:51 PM
protagonist12
08/19/15 11:51 PM
protagonist12
08/19/15 11:49 PM
TREND1
08/19/15 11:48 PM
protagonist12
08/19/15 11:44 PM
TREND1
08/19/15 11:41 PM
protagonist12
08/19/15 11:38 PM
TREND1
08/19/15 10:07 PM
protagonist12
08/11/15 10:08 PM
librarianlover
08/11/15 9:16 PM
protagonist12
08/11/15 7:07 PM

Global Blood Therapeutics (GBT)

Followers
10
Posters
20
Posts (Today)
0
Posts (Total)
39
Created
08/11/15
Type
Free
Moderators
Global Blood Therapeutics is biopharmaceutical firm that develops therapeutics for blood-based disorders. Its lead product candidate is GBT440, a once-daily oral prophylactic therapy for sickle cell disease (SCD), currently in Phase 1/2 development. GBT440 also being developed for the treatment of acute and chronic hypoxemic(inadequate levels of oxygen in the blood) pulmonary disorders. Additionally, its pipeline includes several small molecule kallikrein inhibitors for the prevention of angioedema attacks. SCD affects ~100K Americans and ~60K Europeans each year. The global incidence is ~300K per year. 2014 Financials ($M): Operating Expenses: 20.5 (+31.0%); Net Loss: (20.8) (-14.9%); Cash Burn: (20.1) (-36.9%).
Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
Upgrade to Real-Time
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Detailed Quote
GBT Latest News
More GBT News
Most Liked Posts
(Last 30 Days)
New Post